{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:12Z","timestamp":1789632192862,"version":"build-2803163510"},"reference-count":10,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15829","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:24:25Z","timestamp":1787311465000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review"],"prefix":"10.3892","volume":"32","author":[{"given":"Shintaro","family":"Yamanaka","sequence":"first","affiliation":[{"name":"Cancer Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yakushijin","sequence":"additional","affiliation":[{"name":"Cancer Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hasebe","sequence":"additional","affiliation":[{"name":"Cancer Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Cancer Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Palliative Care Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketsugu","family":"Fujibuchi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Ehime University Graduate School of Medicine, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Kidani","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Ehime University Graduate School of Medicine, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Maruta","sequence":"additional","affiliation":[{"name":"Cancer Center, Ehime University Hospital, Toon, Ehime 791\u20110295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"key20260917101321_b1-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.athoracsur.2015.07.087","article-title":"Surgical treatment of primary cardiac sarcomas: Review of a single-institution experience","volume":"101","author":"Ramlawi","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"key20260917101321_b2-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.jacc.2020.03.041","article-title":"Long-term outcomes of primary cardiac malignancies: Multi-institutional results from the National Cancer Database","volume":"75","author":"Sultan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"key20260917101321_b3-ol-32-4-15829","first-page":"58","article-title":"Primary cardiac sarcoma: Insights from two decades of multimodal management at LMU Munich","volume":"11","author":"Burkhard-Meier","year":"2025","journal-title":"Cardiooncology"},{"key":"key20260917101321_b4-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"102617","DOI":"10.1016\/j.ctrv.2023.102617","article-title":"Multimodality treatment of primary cardiac angiosarcoma: A systematic literature review","volume":"120","author":"Stergioula","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"key20260917101321_b5-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"1","DOI":"10.34172\/jcvtr.2023.30531","article-title":"Clinical characteristics, management, and outcomes of patients with primary cardiac angiosarcoma: A systematic review","volume":"15","author":"Chambergo-Michilot","year":"2023","journal-title":"J Cardiovasc Thorac Res"},{"key":"key20260917101321_b6-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"bcr2016214575","DOI":"10.1136\/bcr-2016-214575","article-title":"Embolic superior mesenteric artery (SMA) occlusion secondary to a cardiac sarcoma","volume":"2016","author":"Robinson","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key20260917101321_b7-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1200\/JCO.20.00714","article-title":"Randomized comparison of pazopanib and doxorubicin as first-line treatment in patients with metastatic soft tissue sarcoma age 60 years or older: Results of a German intergroup study","volume":"38","author":"Gr\u00fcnwald","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20260917101321_b8-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"Van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"key20260917101321_b9-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10147-023-02453-4","article-title":"Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan","volume":"29","author":"Nakamura","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"key20260917101321_b10-ol-32-4-15829","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/annonc\/mdt586","article-title":"Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: Subanalysis of two European Organisation for research and treatment of cancer (EORTC) clinical trials 62043 and 62072","volume":"25","author":"Kasper","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:57Z","timestamp":1789629237000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15829","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}